• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

HLA-B*58:01 is strongly associated with allopurinol-induced severe cutaneous adverse reactions in Han Chinese patients: a multicentre retrospective case-control clinical study.

作者信息

Cheng L, Xiong Y, Qin C Z, Zhang W, Chen X P, Li J, Zhou H H

机构信息

Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.

Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, 410078, Hunan, China.

出版信息

Br J Dermatol. 2015 Aug;173(2):555-8. doi: 10.1111/bjd.13688. Epub 2015 Jun 22.

DOI:10.1111/bjd.13688
PMID:26104483
Abstract
摘要

相似文献

1
HLA-B*58:01 is strongly associated with allopurinol-induced severe cutaneous adverse reactions in Han Chinese patients: a multicentre retrospective case-control clinical study.HLA - B*58:01与汉族患者中别嘌醇诱导的严重皮肤不良反应密切相关：一项多中心回顾性病例对照临床研究。
Br J Dermatol. 2015 Aug;173(2):555-8. doi: 10.1111/bjd.13688. Epub 2015 Jun 22.
2
Genotyping to Prevent Cases of DRESS and SJS/TEN in East Asians Treated with Allopurinol-A Canadian Missed Opportunity.基因分型预防东亚地区接受别嘌醇治疗患者发生药物超敏反应伴嗜酸性粒细胞增多和系统症状（DRESS）及重症多形红斑/中毒性表皮坏死松解症（SJS/TEN）——加拿大错失的机会
J Cutan Med Surg. 2019 Nov/Dec;23(6):595-601. doi: 10.1177/1203475419867599. Epub 2019 Aug 5.
3
HLA-B*5801: utility and cost-effectiveness in the Asia-Pacific Region.HLA-B*5801：在亚太地区的实用性和成本效益。
Int J Rheum Dis. 2013 Jun;16(3):254-7. doi: 10.1111/1756-185X.12050. Epub 2013 Apr 26.
4
A Personalized Medicine Approach to Guide Allopurinol Use and Prevent Serious Adverse Events: Ethnicity Is Not a Proxy for Genetics.一种指导别嘌醇使用并预防严重不良事件的个性化医疗方法：种族并非遗传学的替代指标。
Clin Pharmacol Ther. 2021 Oct;110(4):852-854. doi: 10.1002/cpt.2124. Epub 2020 Dec 16.
5
Genetic susceptibilities and prediction modeling of carbamazepine and allopurinol-induced severe cutaneous adverse reactions in Vietnamese.越南人群中卡马西平和别嘌醇诱导严重皮肤不良反应的遗传易感性和预测模型。
Pharmacogenomics. 2021 Jan;22(1):1-12. doi: 10.2217/pgs-2019-0146. Epub 2020 Dec 24.
6
HLA-B allele associations with certain drugs are not confirmed in Japanese patients with severe cutaneous drug reactions.在患有严重皮肤药物不良反应的日本患者中，HLA - B等位基因与某些药物之间的关联未得到证实。
Acta Derm Venereol. 2008;88(6):616-8. doi: 10.2340/00015555-0528.
7
HLA-B*58:01 strongly associates with allopurinol-induced adverse drug reactions in a Japanese sample population.在日本样本人群中，HLA - B*58:01与别嘌醇引起的药物不良反应密切相关。
J Dermatol Sci. 2013 Aug;71(2):150-2. doi: 10.1016/j.jdermsci.2013.04.013. Epub 2013 Apr 19.
8
Clinical Pharmacogenetics Implementation Consortium guidelines for human leukocyte antigen-B genotype and allopurinol dosing.临床药物遗传学实施联盟 HLA-B 基因型和别嘌醇剂量指南。
Clin Pharmacol Ther. 2013 Feb;93(2):153-8. doi: 10.1038/clpt.2012.209. Epub 2012 Oct 17.
9
HLA-B*58:01 is a risk factor for allopurinol-induced DRESS and Stevens-Johnson syndrome/toxic epidermal necrolysis in a Portuguese population.HLA-B*58:01 是葡萄牙人群中别嘌醇诱导的 DRESS 和 Stevens-Johnson 综合征/中毒性表皮坏死松解症的危险因素。
Br J Dermatol. 2013 Sep;169(3):660-5. doi: 10.1111/bjd.12389.
10
Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population.在泰国人群中，HLA - B*5801与别嘌醇诱发的史蒂文斯 - 约翰逊综合征及中毒性表皮坏死松解症之间存在强关联。
Pharmacogenet Genomics. 2009 Sep;19(9):704-9. doi: 10.1097/FPC.0b013e328330a3b8.

引用本文的文献

1
HLA-B*58:01 genotyping prevalence and the association with allopurinol-induced severe cutaneous adverse reactions: a living systematic review and meta-analysis.HLA - B*58:01基因分型患病率及其与别嘌醇诱导的严重皮肤不良反应的关联：一项实时系统评价和荟萃分析。
Sci Rep. 2025 Aug 21;15(1):30742. doi: 10.1038/s41598-025-16062-w.
2
Updates in the pathogenesis of SJS/TEN.史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症发病机制的最新进展。
Allergol Int. 2025 Jul;74(3):361-371. doi: 10.1016/j.alit.2025.05.002. Epub 2025 Jun 4.
3
The association between the number of HLA risk alleles and drug allergy and its implications for HLA screening - a case-control study.
HLA风险等位基因数量与药物过敏之间的关联及其对HLA筛查的意义——一项病例对照研究。
Pharmacogenomics J. 2025 Feb 18;25(2):1. doi: 10.1038/s41397-025-00362-5.
4
Comparison of clinical and economic evaluation between selected generic and original febuxostat tablets in Chinese gout patients with hyperuricemia: A real-world multicenter retrospective study.中国高尿酸血症痛风患者中选择的通用与原研非布司他片的临床与经济学评价比较：一项真实世界多中心回顾性研究。
Medicine (Baltimore). 2024 Jan 26;103(4):e37081. doi: 10.1097/MD.0000000000037081.
5
Assessing pharmacogenomic literacy in China through validation of the Chinese version of the Minnesota Assessment of Pharmacogenomic Literacy.通过验证中文版明尼苏达州药物基因组学素养评估量表来评估中国的药物基因组学素养。
Clin Transl Sci. 2023 Nov;16(11):2356-2368. doi: 10.1111/cts.13637. Epub 2023 Oct 6.
6
WGCNA-Based DNA Methylation Profiling Analysis on Allopurinol-Induced Severe Cutaneous Adverse Reactions: A DNA Methylation Signature for Predisposing Drug Hypersensitivity.基于加权基因共表达网络分析的别嘌醇诱导的严重皮肤不良反应的DNA甲基化谱分析：一种药物超敏反应易感性的DNA甲基化特征
J Pers Med. 2022 Mar 24;12(4):525. doi: 10.3390/jpm12040525.
7
Current Pharmacogenetic Perspective on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的当前药物遗传学观点
Front Pharmacol. 2021 Apr 26;12:588063. doi: 10.3389/fphar.2021.588063. eCollection 2021.
8
Diagnostic Test Criteria for HLA Genotyping to Prevent Drug Hypersensitivity Reactions: A Systematic Review of Actionable HLA Recommendations in CPIC and DPWG Guidelines.预防药物超敏反应的HLA基因分型诊断测试标准：对CPIC和DPWG指南中可操作的HLA建议的系统评价
Front Pharmacol. 2020 Sep 23;11:567048. doi: 10.3389/fphar.2020.567048. eCollection 2020.
9
Allopurinol-induced hypersensitivity syndrome followed by painless thyroiditis in a patient with asymptomatic hyperuricemia.无症状高尿酸血症患者发生别嘌醇诱发的超敏反应综合征，随后出现无痛性甲状腺炎。
Arch Med Sci. 2020 Aug 10;16(5):1254-1256. doi: 10.5114/aoms.2020.97971. eCollection 2020.
10
Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysis.史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症管理与认识的最新进展
F1000Res. 2020 Jun 16;9. doi: 10.12688/f1000research.24748.1. eCollection 2020.